An importing industry of national priority

The pharmaceutical industry in Mexico accounts for a significant share of the country’s economy, bringing in more than 70 billion Mexican pesos in 2019. With a production value of nearly 150 billion Mexican pesos that same year, the pharmaceutical market employed almost 53 thousand people in total. Despite its significant role in the national economy, Mexico’s pharma industry relies mostly on imports. Together, the United States and Germany accounted for nearly half of the total imports. Additionally, medications consisting of mixed or unmixed products for therapeutic or prophylactic uses gathered almost two thirds of this value.

COVID-19 vaccine marathon

More than one thousand drugs and vaccines targeting the coronavirus (COVID-19) disease were in development worldwide as of February 2021. The number goes down to 17 clinical studies completed in Mexico, hoping to find a cure to the pandemic that has threatened millions of lives. With 14 candidates already launched, countries all over the world had started negotiations and acquisition of the different vaccines, along with immunization campaigns that have allowed more than 205 million doses to be administered. Thus, clinical studies have not been more important for the pharmaceutical industry. A higher spending on research and development will speed up the process of new drugs becoming available on the market, not only in the case of pandemics, but also to fight diseases that have continuously burden global public health for decades.

This text provides general information. Statista assumes no liability for the information given being complete or correct. Due to varying update cycles, statistics can display more up-to-date data than referenced in the text.